India Pharma Outlook’s Post

🔬Explore how #artificialintelligence and #machinelearning can significantly transform #pharmacovigilance practices. Our comprehensive resource delves into the potential of #AI and #ML technologies in automating adverse event detection, signal detection, and safety monitoring. Read more at: https://hubs.li/Q02tf-xt0 Interested in learning about our Safety and PV solutions? Read more here: https://hubs.li/Q02tfVqK0 #CTMS #eTMF #EDC #RTSM #Safety #PV #Pharmaceutical #Biotechnology #MedicalDevices #Diagnostics #Cloudbyz #ClinicalTrials #DrugSafety #ArtificialIntelligence #MachineLearning #PatientSafety #Salesforce

🔬Explore how #artificialintelligence and #machinelearning can significantly transform #pharmacovigilance practices. Our comprehensive resource delves into the potential of #AI and #ML technologies in automating adverse event detection, signal detection, and safety monitoring. Read more at: https://hubs.li/Q02tfW8q0 Interested in learning about our Safety and PV solutions? Read more here: https://hubs.li/Q02tg0_K0 #CTMS #eTMF #EDC #RTSM #Safety #PV #Pharmaceutical #Biotechnology #MedicalDevices #Diagnostics #Cloudbyz #ClinicalTrials #DrugSafety #ArtificialIntelligence #MachineLearning #PatientSafety #Salesforce

🔬Explore how #artificialintelligence and #machinelearning can significantly transform #pharmacovigilance practices. Our comprehensive resource delves into the potential of #AI and #ML technologies in automating adverse event detection, signal detection, and safety monitoring. Read more at: https://hubs.li/Q02tfNNj0 Interested in learning about our Safety and PV solutions? Read more here: https://hubs.li/Q02tfV8T0 #CTMS #eTMF #EDC #RTSM #Safety #PV #Pharmaceutical #Biotechnology #MedicalDevices #Diagnostics #Cloudbyz #ClinicalTrials #DrugSafety #ArtificialIntelligence #MachineLearning #PatientSafety #Salesforce

🔬Explore how #artificialintelligence and #machinelearning can significantly transform #pharmacovigilance practices. Our comprehensive resource delves into the potential of #AI and #ML technologies in automating adverse event detection, signal detection, and safety monitoring. Read more at: https://hubs.li/Q02tfV8V0 Interested in learning about our Safety and PV solutions? Read more here: https://hubs.li/Q02tfNQ30 #CTMS #eTMF #EDC #RTSM #Safety #PV #Pharmaceutical #Biotechnology #MedicalDevices #Diagnostics #Cloudbyz #ClinicalTrials #DrugSafety #ArtificialIntelligence #MachineLearning #PatientSafety #Salesforce Salesforce

The application of AI in patient monitoring and post-marketing surveillance is at the top of Clientelis solutions pipeline

🔬 Transforming #pharmacovigilance and ensuring drug/device safety with #AI and #ML. AI/ML algorithms are significantly transforming the way safety data is analyzed, adverse events are detected, and risks are mitigated. Read on to explore some of the key AI/ML use cases in pharmacovigilance and drug/device safety: https://hubs.li/Q02nqCZ00 Sign up for our webinar: "From Legacy to Leading Edge: Embracing Next-Gen CTMS" on Thursday, March 28 2024, at 11 AM EST: https://hubs.li/Q02nqBHF0 #CTMS #eTMF #EDC #RTSM #Safety #PV #Pharmaceutical #Biotechnology #MedicalDevices #Diagnostics #Cloudbyz #ClinicalTrials #DrugSafety #ArtificialIntelligence #MachineLearning #PatientSafety

🔬💡 Cutting Pharmacovigilance Costs with AI Pharmacovigilance, the practice of monitoring drug safety, is compulsory but costly. The average cost per case is $90 (Deloitte). With cases rising tenfold over the past 20 years and continuing to grow at 15% annually (FDA), there's a clear need for efficiency. The burden of regulation by authorities like the FDA, WHO, and EMA is also increasing. These organizations are implementing stricter guidelines and requirements for monitoring and reporting adverse drug reactions. This heightened regulatory scrutiny, while crucial for patient safety, adds to the workload and costs for pharmaceutical companies. AI as a Solution: AI is transforming pharmacovigilance by automating data collection and analysis, improving signal detection, streamlining reporting, and enhancing predictive capabilities. These advancements can reduce the need for extensive human resources and minimize errors, leading to significant cost savings. AI also facilitates outsourcing tasks to qualified professionals in low-cost regions, further reducing expenses while maintaining high standards. Estimated Cost and Time Savings: Cost Savings: Automating tasks can cut the average cost per case by up to 50%.  Time Savings: AI can reduce the time required for data processing and reporting by up to 70%, completing tasks in days instead of weeks. Outsourcing Benefits: Outsourcing AI-driven tasks to low-cost regions can further cut operational costs by 20-30%. Integrating AI into pharmacovigilance processes offers substantial cost reductions and improved drug safety. Clientelis is at the forefront of AI-powered pharmaceutical services. 🚀 #AI #Pharmacovigilance #HealthcareInnovation #PatientSafety #CostEfficiency #Clientelis #Surveillance #Postmarketing #AdverseEvent #PharmaceuticalServices #BPO #PV #Materiovigilance #PharmaceuticalServices #Compliance

“The first step in exceeding your customer's expectations is to know those expectations.” ~Roy H. Williams We are extremely grateful for the trust our clients have placed in our abilities to meet their business needs. A big shout out to the Nextrove team for the successful implementation of one of our Progressive solutions: Global Follow-up Automation (GFA). Read the case study to explore how we completely transformed and automated the labor-intensive follow-up process in Pharmacovigilance for a top pharmaceutical organization. #NEXTROVE, Empowering Clients to Improve Patient Safety. #Safety #DrugSafety #RegulatoryScience #Innovation #clinicaltrials #pharmacovigilance #pharma #lifesciences #lifescience #lifescienceindustry #drugdevelopment #drugmanufacturing #pharmaceutical #globalhealth #riskmanagement #hostingservices #patientsafety #pharmacovigilance #drugsafety #safety #artificialintelligence #ai #automation

The role of pharmacovigilance is monitoring safety of marketed drugs and investigational products to support and ensure patient safety. Nextrove collaborated with the Client and launched a project to optimize and automate the follow-up data collection process by leveraging Progressive GFA. Read the Case study: https://lnkd.in/etdrBQyN #NEXTROVE, Empowering Clients to Improve Patient Safety.   #Safety #DrugSafety #RegulatoryScience #Innovation #clinicaltrials #pharmacovigilance #pharma #lifesciences #lifescience #lifescienceindustry #drugdevelopment #drugmanufacturing #pharmaceutical #globalhealth #riskmanagement #hostingservices #patientsafety #pharmacovigilance #drugsafety #safety

Nextrove Progressive Global Follow-up Automation (GFA) solution transformed the entire follow-up process at a top tier Pharmaceutical Company. Read the Case Study ➡ https://lnkd.in/etdrBQyN #NEXTROVE, Empowering Clients to Improve Patient Safety. #Safety #DrugSafety #RegulatoryScience #Innovation #clinicaltrials #pharmacovigilance #pharma #lifesciences #lifescience #lifescienceindustry #drugdevelopment #drugmanufacturing #pharmaceutical #globalhealth #riskmanagement #hostingservices #patientsafety #pharmacovigilance #drugsafety #safety #artificialintelligence #ai #automation